CellCure Neurosciences Ltd.
Sector: Biotechnology - Therapeutics
Medical Field: Neurology and Degenerative Diseases
Technological Field: Regenerative Medicine - Stem Cell Therapy
Year Established: 2005
Cell Cure Neurosciences was established towards the end of 2005 as an Israeli subsidiary of ES Cell International Pte Ltd with a well defined mission to develop cell-therapy products for the cure of neurodegenerative disorders. The initial effort is to turn human embryonic stem cells into dopamine producing nerve-cells for the cure of Parkinson's disease and motor neurons for ALS.
The company operates within the laboratory facilities of Hadassah University Hospital, with a cGMP facility included. With the recent investment made by Hadasit Bio-Holding Ltd and government grants tailored for stem-cell research, the highly qualified and dedicated team of Cell Cure expects to preserve an already attained leadership in the development of cures for disorders of the nervous system (e.g. ALS, Parkinson’s disease and Multiple Sclerosis).